38 related articles for article (PubMed ID: 38594780)
21. Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications.
Gou HF; Chen XC; Zhu J; Jiang M; Yang Y; Cao D; Hou M
J Exp Clin Cancer Res; 2011 Jan; 30(1):14. PubMed ID: 21272377
[TBL] [Abstract][Full Text] [Related]
22. COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer.
Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
Anat Rec (Hoboken); 2010 Nov; 293(11):1838-46. PubMed ID: 20830783
[TBL] [Abstract][Full Text] [Related]
23. Changing trends in incidence of ovarian cancer - the Indian scenario.
Murthy NS; Shalini S; Suman G; Pruthvish S; Mathew A
Asian Pac J Cancer Prev; 2009; 10(6):1025-30. PubMed ID: 20192577
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway.
Chien MH; Ku CC; Johansson G; Chen MW; Hsiao M; Su JL; Inoue H; Hua KT; Wei LH; Kuo ML
Carcinogenesis; 2009 Dec; 30(12):2005-13. PubMed ID: 19825968
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer.
Guo X; Chen Y; Xu Z; Xu Z; Qian Y; Yu X
Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):217-22. PubMed ID: 19280060
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of human endothelial nitric oxide synthase promoter activity by p38 mitogen-activated protein kinase activation.
Xing F; Jiang Y; Liu J; Zhao K; Mo Y; Liu Z; Zeng Y
Biochem Cell Biol; 2006 Oct; 84(5):780-8. PubMed ID: 17167542
[TBL] [Abstract][Full Text] [Related]
27. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
Yang J; Wu HF; Qian LX; Zhang W; Hua LX; Yu ML; Wang Z; Xu ZQ; Sui YG; Wang XR
Asian J Androl; 2006 Mar; 8(2):169-75. PubMed ID: 16491267
[TBL] [Abstract][Full Text] [Related]
28. Nuclear localization of long-VEGF is associated with hypoxia and tumor angiogenesis.
Rosenbaum-Dekel Y; Fuchs A; Yakirevich E; Azriel A; Mazareb S; Resnick MB; Levi BZ
Biochem Biophys Res Commun; 2005 Jun; 332(1):271-8. PubMed ID: 15896327
[TBL] [Abstract][Full Text] [Related]
29. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
[TBL] [Abstract][Full Text] [Related]
30. COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma.
Kyzas PA; Stefanou D; Agnantis NJ
Mod Pathol; 2005 Jan; 18(1):153-60. PubMed ID: 15272284
[TBL] [Abstract][Full Text] [Related]
31. Future directions in the surgical management of ovarian cancer.
Berman ML
Gynecol Oncol; 2003 Aug; 90(2 Pt 2):S33-9. PubMed ID: 12928004
[TBL] [Abstract][Full Text] [Related]
32. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
[TBL] [Abstract][Full Text] [Related]
33. A prognostic model for ovarian cancer.
Clark TG; Stewart ME; Altman DG; Gabra H; Smyth JF
Br J Cancer; 2001 Sep; 85(7):944-52. PubMed ID: 11592763
[TBL] [Abstract][Full Text] [Related]
34. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis.
Hamada K; Oike Y; Takakura N; Ito Y; Jussila L; Dumont DJ; Alitalo K; Suda T
Blood; 2000 Dec; 96(12):3793-800. PubMed ID: 11090062
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide synthases: which, where, how, and why?
Michel T; Feron O
J Clin Invest; 1997 Nov; 100(9):2146-52. PubMed ID: 9410890
[No Abstract] [Full Text] [Related]
36. Genomic organization of human and mouse genes for vascular endothelial growth factor C.
Chilov D; Kukk E; Taira S; Jeltsch M; Kaukonen J; Palotie A; Joukov V; Alitalo K
J Biol Chem; 1997 Oct; 272(40):25176-83. PubMed ID: 9312130
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.
Stamler JS; Jaraki O; Osborne J; Simon DI; Keaney J; Vita J; Singel D; Valeri CR; Loscalzo J
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7674-7. PubMed ID: 1502182
[TBL] [Abstract][Full Text] [Related]
38. Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient.
Bhaskari J; Bhagat R; Shilpa V; Premalata CS; Krishnamoorthy L
J Ovarian Res; 2024 Apr; 17(1):77. PubMed ID: 38594780
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
